Home / Europe / Switzerland / Life Sciences & Healthcare

Life Sciences & Healthcare

Think globally, act locally

Rising regulatory requirements, increasing price and cost pressures, and new technological advancements pose major challenges for companies operating in the life sciences and health care sectors. To succeed in this dynamic and rapidly changing environment, companies need a partner with a global perspective who is thoroughly versed in the local market environment. CMS is just that partner for you.

A Global Perspective.

The CMS Life Sciences and Healthcare Sector Group consists of over 480 lawyers across Europe. Our multidisciplinary team advises you on every aspect along the business cycle of a product or service. We assist you with company formation, financing or finding business partners, protecting innovations as well as implementing your business strategy in Switzerland or adapting to the regulatory environment of the Swiss healthcare market. Our market knowledge and multidisciplinary advice is appreciated by world-renowned manufacturers of pharmaceuticals or medical devices as well as by young start-up companies or domestic service providers, such as hospitals, pharmacy groups or doctors with their own practice.

We have a long standing experience in supporting our Life Sciences and Healthcare clients in:

  • Research and development (particularly in clinical trials)
  • Patent enforcement
  • Regulatory authorisations
  • Advertising and distribution issues
  • Pricing strategies and reimbursements under social security law
  • Compliance
  • Liability issues
  • Data protection

We provide truly full service.

When Experience Matters.

Whether it is the launch of a new therapy, an adaptation to regulatory requirements in Switzerland, an international patent dispute, the formation of a strategic alliance or a merger with a competitor, we know your market environment and understand how we can support you in taking the next steps. Together with you, we ask the right questions and find creative solutions. In doing so, we anticipate risks and solve problems before they arise. We advise you on your contracts or defend your interests before civil and administrative courts. Whatever challenges you face, wherever the problem lies: The CMS team has exactly the right solution for you!

Our clients include:

  • Bayer
  • Vista Klinik
  • Mobile Health
  • Pfizer
  • GE Healthcare
  • Takeda
  • Eli Lilly
  • Zur Rose 

Recent highlights of our work:

  • Representing Bayer (Switzerland), the Swiss branch of the leading Germany-based global pharmaceuticals manufacturer.  Our Switzerland-based competition/antitrust team is advising Bayer in the highly-contested Swiss administrative proceedings regarding price recommendations for medication against erectile dysfunction traded over-the-counter. 
  • Advising mobile Health AG in connection with Consilium Care™, an electronic Patient Reported Outcomes (ePRO) SaaS system which includes the CE-marked MDD Class I medical device, Pro Care. Pro Care improves the symptoms progression monitoring for cancer patients, as well as the monitoring of their wellbeing (based on the ECOG scale).
  • Supporting Vista Klinik on building its acquisition portfolio of clinics across Switzeralnd.
  • Representation of marketing authorization holders in appeal proceedings before the Federal Supreme Court and the Federal Administrative Court concerning the inclusion of medicinal products in the list of specialities and the triennial price review by the Federal Office of Public Health (FOPH) .
  • Representation of manufacturers of inhalation devices in appeal proceedings before the Federal Administrative Court concerning adjustment of the list of medicinal products and medical devices (MiGeL).
  • Representation of medical suppliers in cantonal administrative proceedings concerning cooperation with physicians for undue benefits.
  • Representing and advising hospital managers in criminal proceedings concerning the handling of medical devices.

Find an expert

'Due to very good networking', CMS 'can provide know-how in a variety of matters', especially at a multi-jurisdictional level. Regulatory, compliance, financial benefits and pricing advice, as well as the negotiation of agreements and representation in court form the main areas of expertise.

The Legal 500, Healthcare and life sciences, Switzerland, 2019

Choose an area

Nach einer von CMS Schweiz bei allen Stakeholdern durchgeführten Umfrage gehört der demografische Wandel und der Fachkräftemangel zu de


Cannabis law and legislation in Switzerland
Medical use As of 1 August 2022, the Swiss Federal Narcotics Act was amended to allow the use of cannabis for medical purposes. The amended narcotics law allows cannabis to be cultivated, processed, traded...
Updated CMS Expert Guide to Cannabis law and legislation
CMS Expert Guide on cannabis law and legislation gives stakeholders detailed and updated information on the latest developments in cannabis regulation in key markets.  The Guide now covers 33 jurisdictions...
What’s in a name? The use of a product code in a clinical trial protocol...
The use of product or sponsor codes in clinical trial related documents is common practice in the pharmaceutical space. However, such codes may not always be sufficient to disregard a publication as relevant...
A broader interpretation of "substance or composition" - good news for...
A recent decision from the EPO Boards of Appeal (T 1252/20) potentially paves the way for more diverse products to be patentable in Europe using the medical use claim format.The back­ground:Art­icle 53(c)...
Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? 1.1 Medicines  The key statutes regulating advertising and promotion of medicinal products are:The Federal Act...
CMS Switzerland earns renewed recognition as a leading law firm
Once again, CMS distinguishes itself as a leader in Switzerland's legal landscape, according to the "Top Law Firm" rankings from the Swiss business magazines BIL­ANZ, the Han­delszei­tung and magazine PME. Across 31 distinct practice areas, CMS von Erlach Partners (CMS Switzerland) has solidified its position among the elite, securing top 25 rankings in an impressive 25 practice areas. This reaffirms our standing as a leading full-service law firm in Switzerland. 
Navigating clinical trial disclosures: No reasonable expectation of success...
Recent EPO Board of Appeal decision T 1437/21 adds to a growing number of decisions concerning the patentability of second or further medical use inventions where the prior art relates to a clinical trial...
CMS advised Vista Augenpraxis & Kliniken on the acquisition of Augenzentrum...
Zurich, March 2024 | Vista Klinik Holding AG, domiciled in Binningen (Switzerland), integrated into its network Augenzentrum Muttenz-Pratteln GmbH, a renowned provider of ophthalmological services in Baselland. The eye centre operates a total of three ultra-modern sites in the municipalities of Muttenz and Pratteln with first-class medical equipment, including state-of-the-art surgery facilities (focused on intravitreal injections). Founded over 30 years ago, Vista Augenpraxen & Kliniken has become a leading centre of excellence for ophthalmology in Switzerland. With its numerous locations, Vista has a broad network of eye clinics and eye practices. At all sites, specialised ophthalmologists offer all treatments and surgical interventions relating to the eye. In this way, Vista guarantees comprehensive and lifelong care for its patients. Forward-looking research activities and the continuous training of all employees ensure quality and sustainability at all sites. A team of CMS Switzerland, led by Stefan Brunnschweiler and Franziska Hammer, advised Vista Augenpraxen & Kliniken on all legal matters of the transaction. CMS Switzer­land­Stefan Brunnschweiler, Partner, Corporate / M&AFranziska Hammer, Counsel, Corporate / M&A          Christoph Willi, Partner, Life Science & HealthcareMiryam Meile, Associate, EmploymentRafael Gruber, Attorney Trainee
CMS Switzerland recognised by The Legal 500 EMEA 2024
This year CMS Switzerland has been recommended by The Legal 500 in 21 categories in the European, Middle Eastern and African (EMEA) edi­tion. In addition, 6 of our lawyers are recognized individually for their expertise as "Leading Individuals" or "Next Generation Partner" in the areas of Competition, Insolvency & Corporate Recovery, Insurance, Public Law, Real Estate & Construction and TMT.
Patentability of inventions relating to diagnostic methods at the EPO
Under Article 53(c) of the European Patent Convention (EPC), diagnostic methods practised on the human or animal body are excluded from patentability. The purpose behind this exclusion is to avoid patent...
Digital health apps and telemedicine in Switzerland
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? 1.1 Is it considered a “medical device” or a “product”...
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...